RESUMEN
In order to evaluate the possibility to administer high FUDR doses, 52 patients with liver metastases were treated with loco-regional chemotherapy associated with venous hemofiltration. The clinical and pharmacological results of this approach are discussed.
Asunto(s)
Floxuridina/administración & dosificación , Hemofiltración/métodos , Neoplasias Hepáticas/terapia , Adulto , Anciano , Cateterismo Venoso Central , Terapia Combinada , Humanos , Infusiones Intraarteriales , Neoplasias Hepáticas/tratamiento farmacológico , Neoplasias Hepáticas/secundario , Persona de Mediana Edad , Estudios RetrospectivosRESUMEN
Hemodialyzed patients mean an high-risk population for hepatitis C infection. Our work was performed to evaluate the incidence of hepatitis C virus (HCV) infection in 51 hemodialyzed patients; the presence of anti-HCV antibodies was studied using the EIA and RIBA test of 1st and 2nd generation. 18 patients (35.29%) showed anti-HCV antibodies with the 1st test; 27 patients (52.94%) showed the presence of anti-HCV antibodies using 2nd generation test. The incidence of test positivity is not related to blood transfusions while it is strictly related with dialytic age. All HCV seropositive patients show antibodies against the c22-3 protein of "virus core". The presence in serum of anti-c22-3 antibodies means that in these patients, there is viral replication.
Asunto(s)
Hepatitis C/etiología , Diálisis Renal/efectos adversos , Hepacivirus/inmunología , Anticuerpos Antihepatitis/sangre , Hepatitis C/inmunología , Hepatitis C/transmisión , Humanos , Factores de TiempoRESUMEN
The exact pathogenesis of hepatic coma is unknown and this fact has stimulated research in the field of hemodetoxification treatment. We studied 31 patients (19 M and 12 F) with acute hepatic failure and used different detoxification techniques such as hemodialysis, hemoperfusion, hemofiltration and plasmaferesis. We evaluated blood tests, degree of coma and serum levels of middle-molecular weight substances (by gel-chromatography) for each patient. Our results show that there was an improvement of consciousness and general clinical state in 40% of patients who underwent HD, in 50% of patients treated with HP, in 37.5% of those treated with PF and 78% of patients treated with HF. Unfortunately, the improvement did not last long. In conclusion we can say that artificial support improves hepatic coma and state of consciousness. This improvement could be due to the better regeneration possibilities of hepatic cells. For this reason hemodetoxification treatment should be started as soon as possible.
